CN114173878A - 拟肽大环化合物及其用途 - Google Patents

拟肽大环化合物及其用途 Download PDF

Info

Publication number
CN114173878A
CN114173878A CN202080036270.1A CN202080036270A CN114173878A CN 114173878 A CN114173878 A CN 114173878A CN 202080036270 A CN202080036270 A CN 202080036270A CN 114173878 A CN114173878 A CN 114173878A
Authority
CN
China
Prior art keywords
day
days
peptidomimetic macrocycle
administration
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080036270.1A
Other languages
English (en)
Chinese (zh)
Inventor
沃伊斯拉夫·武科维奇
路易斯·卡瓦哈尔
D·A·安尼斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rein Therapeutics Inc
Original Assignee
Aileron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aileron Therapeutics Inc filed Critical Aileron Therapeutics Inc
Publication of CN114173878A publication Critical patent/CN114173878A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CN202080036270.1A 2019-03-15 2020-03-13 拟肽大环化合物及其用途 Pending CN114173878A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962819195P 2019-03-15 2019-03-15
US62/819,195 2019-03-15
US201962926018P 2019-10-25 2019-10-25
US62/926,018 2019-10-25
PCT/US2020/022682 WO2020190742A1 (en) 2019-03-15 2020-03-13 Peptidomimetic macrocycles and uses thereof

Publications (1)

Publication Number Publication Date
CN114173878A true CN114173878A (zh) 2022-03-11

Family

ID=72424829

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080036270.1A Pending CN114173878A (zh) 2019-03-15 2020-03-13 拟肽大环化合物及其用途

Country Status (7)

Country Link
US (1) US20200289609A1 (cg-RX-API-DMAC7.html)
EP (1) EP3938051A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022525416A (cg-RX-API-DMAC7.html)
CN (1) CN114173878A (cg-RX-API-DMAC7.html)
AU (1) AU2020241429A1 (cg-RX-API-DMAC7.html)
CA (1) CA3132993A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020190742A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022007461A1 (zh) * 2020-07-04 2022-01-13 成都先导药物开发股份有限公司 一种免疫调节剂
CN118742556A (zh) * 2021-11-29 2024-10-01 默沙东有限责任公司 针对mdm2/mdmx的c-端延伸的p53激活剂交联的拟肽大环化合物
WO2023107353A2 (en) * 2021-12-10 2023-06-15 Merck Sharp & Dohme Llc P53 peptidomimetic macrocycles

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103282510A (zh) * 2010-08-13 2013-09-04 爱勒让治疗公司 拟肽大环化合物
CN104159595A (zh) * 2012-02-15 2014-11-19 爱勒让治疗公司 拟肽大环化合物
WO2017040990A1 (en) * 2015-09-03 2017-03-09 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2018208954A2 (en) * 2017-05-11 2018-11-15 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0907754A2 (pt) * 2008-02-08 2015-07-21 Aileron Therapeutics Inc Macrociclos peptidomiméticos terapêuticos
JP2018503595A (ja) * 2014-09-24 2018-02-08 エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. ペプチド模倣大環状分子およびその製剤
WO2016154058A1 (en) * 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2017205786A1 (en) * 2016-05-27 2017-11-30 Aileron Therapeutics, Inc. Cell permeable peptidomimetic macrocycles
US11091522B2 (en) * 2018-07-23 2021-08-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103282510A (zh) * 2010-08-13 2013-09-04 爱勒让治疗公司 拟肽大环化合物
CN104159595A (zh) * 2012-02-15 2014-11-19 爱勒让治疗公司 拟肽大环化合物
WO2017040990A1 (en) * 2015-09-03 2017-03-09 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2018208954A2 (en) * 2017-05-11 2018-11-15 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Also Published As

Publication number Publication date
WO2020190742A1 (en) 2020-09-24
EP3938051A1 (en) 2022-01-19
US20200289609A1 (en) 2020-09-17
CA3132993A1 (en) 2020-09-24
EP3938051A4 (en) 2022-12-07
AU2020241429A1 (en) 2021-10-07
JP2022525416A (ja) 2022-05-13

Similar Documents

Publication Publication Date Title
JP6971970B2 (ja) ペプチド模倣大環状分子およびその使用
JP2018536621A5 (cg-RX-API-DMAC7.html)
US20170349638A1 (en) Companion diagnostic tool for peptidomimetic macrocycles
US10471120B2 (en) Peptidomimetic macrocycles and uses thereof
CN107614003A (zh) 拟肽大环化合物及其用途
US11091522B2 (en) Peptidomimetic macrocycles and uses thereof
US20180371021A1 (en) Peptidomimetic macrocycles and uses thereof
US20200289609A1 (en) Peptidomimetic macrocycles and uses thereof
US20230037284A9 (en) Combination therapy of peptidomimetic macrocycles
HK40043424A (en) Peptidomimetic macrocycles and uses thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20220311